Assessment of hearing dysfunction in patients with Graves’ disease and thyroid eye disease without or with teprotumumab
Published: 20 August 2024| Version 1 | DOI: 10.17632/772vxh6fyf.1
Contributor:
Terry SmithDescription
SUPPLEMENT Assessment of hearing dysfunction in patients with Graves’ disease and thyroid eye disease without or with teprotumumab
Files
Institutions
University of Michigan
Categories
Adverse Event, Hearing Loss